ESR1 and cancer: In terms of cancer subtypes, we scrutinised BRCA samples, categorising them into three distinct subtypes: estrogen receptor‐positive (ER+), progesterone receptor‐positive (PR+) and triple‐negative breast cancer, each presenting unique biological characteristics.